Search results
Left Atrial Myxoma
Author(s):
Preet Shaikh
,
Mario Rodriguez Rivera
,
Michael A Beal
,
et al
Added:
1 year ago
Case Report
Pathophysiology, Mechanism, Diagnosis and Management of PAH
Author(s):
Apoorva Gangavelli
,
Ronaldo C Fabiano
,
Mariam Riad
,
et al
Added:
2 months ago
Review Article
John G Coghlan
Job title: Director of the National Pulmonary Hypertension Service
Author
Silvia Ulrich
Author
Robert P Frantz
Research Area(s) / Expertise:
Job title: Assistant Professor of Medicine and Director of the Pulmonary Hypertension Clinic
Author
Maurice Beghetti
Job title: Head of the Paediatric Cardiology Unit
Author
Vineet Agrawal
Job title: Assistant Professor of Medicine
Author
Madelon C Vonk
Job title: Rheumatologist
Author
Author(s):
Harriette Van Spall
,
Luke Laffin
Added:
1 year ago
ACC 25 - ADVANCE-HTN shows lorundrostat, an aldosterone synthase inhibitor, effectively lowered 24-hour blood pressure in patients with uncontrolled and true resistant hypertension.Late-breaker discussion host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Luke Laffin (Cleveland Clinic, Cleveland, OH, US) to discuss the key findings from the ADVANCE-HTN trial…
View more